Form 4: Daxor CFO Robert Michel Plans Future Stock Grant

Daxor Corp's Chief Financial Officer, Robert J. Michel, has reported a planned acquisition of 3,000 shares of common stock scheduled for December 9, 2025.

Summary

• Robert J. Michel, Chief Financial Officer of Daxor Corp (DXR), has reported a planned acquisition of 3,000 shares of common stock.
• This transaction is scheduled to occur on December 9, 2025, and is made pursuant to a Rule 10b5-1 plan.
• The shares will be granted at a price of $0, indicating a stock grant, and are scheduled to vest on the same date, December 9, 2025.
• Following this planned transaction, Michel's beneficial ownership is expected to be 20,050 shares of Daxor Common Stock, held directly.

Sentiment

Score: 7

Explanation: The planned grant of shares to a key executive, the CFO, generally indicates alignment of interests with shareholders and can be seen as a positive signal for management's long-term commitment to the company's performance. However, it is a routine compensation disclosure rather than a significant operational or financial event.

Positives

• The planned grant of 3,000 shares to the Chief Financial Officer aligns management's interests with shareholders, indicating a commitment to the company's long-term performance.

Future Outlook

The filing details a planned future transaction where CFO Robert J. Michel will be granted 3,000 shares of Daxor common stock on December 9, 2025, under a Rule 10b5-1 plan. These shares are also scheduled to vest on the same date.

Industry Context

This filing reports a routine planned insider transaction, which is specific to Daxor Corp and its executive compensation structure, rather than reflecting broader industry trends.

Stakeholder Impact

• Shareholders: The planned stock grant to the CFO is expected to increase alignment between management's financial interests and shareholder value.
• Employees: May signal confidence in the company's future direction and stability.

Next Steps

• Vesting of 3,000 common shares on December 9, 2025, as part of the planned grant.

Key Dates

Recommendation

This Form 4 filing reports a routine planned stock grant to a key executive, which aligns management's interests with shareholders. However, it does not contain sufficient financial or strategic information to warrant a change in investment recommendation. Investors should consider broader company performance and market conditions.

Keywords

DXR, Daxor, Form 4, insider transaction, stock grant, CFO, Robert Michel, beneficial ownership, Rule 10b5-1 plan